Dr. Robert Green shares his insight on the 23andMe initiative and what people should know from these results. “I think this is something that has to be monitored as these services expand their market to less-sophisticated individuals.”
The FDA has cleared 23andMe to resell their small genetic test kit to consumer to find out if they carry a genetic variant for only some diseases. While not all are available to consumers, many are still interested in knowing about these specific 36 that are included in the test.
The cost of integrating genomic sequencing into clinical care seems to be a reasonable and attainable goal in the coming years. While there is still much to be taken into consideration, it could potentially be cost-effective.
How well do people who receive genomic information from direct-to-consumer testing, such as 23andMe, understand their results? The Impact of Personal Genetic Study (PGen) asked consumers to report on their experience.
Meeting with a genetic counselor is a crucial step before getting your genome sequenced because it allows patients to be more informed and prepared to hear and understand the results, especially with women who are being tested for the BRCA1 and BRCA2 gene.